Tech Company Financing Transactions

Variantyx Funding Round

Variantyx, based in Framingham, scored $20 million from Global Health Sciences Fund, 20/20 HealthCare Partners and IBM Ventures.

Transaction Overview

Company Name
Announced On
Transaction Type
Venture Equity
Series C
Proceeds Purpose
The funding will make it possible for Variantyx to extend our technology to comprehensive tumor diagnostic solutions allowing for faster diagnosis and implementation of personalized treatment plans.

Company Information

Company Status
Private & Independent
Healthcare IT
Mailing Address
1671 Worcester Rd. 300
Framingham, MA 01701
Email Address
Variantyx is a CLIA/CAP laboratory providing Genomic Unity, a whole genome sequencing (WGS)-based testing program for diagnosis of rare inherited disorders. Its single method approach to comprehensive genetic testing identifies multiple variant types within a single patient sample to provide a unified clinical report.
Variantyx LinkedIn Company Profile
Social Media
Variantyx Company Twitter Account
Company News
Variantyx News
Variantyx on Facebook
Variantyx on YouTube

Management Team

Email & Social
Chief Executive Officer
Haim Neerman
  Haim Neerman LinkedIn Profile  Haim Neerman Twitter Account  Haim Neerman News  Haim Neerman on Facebook
Chief Operating Officer
Yaron Rachmany
  Yaron Rachmany LinkedIn Profile  Yaron Rachmany Twitter Account  Yaron Rachmany News  Yaron Rachmany on Facebook
Chief Scientific Officer
Noam Shomron
  Noam Shomron LinkedIn Profile  Noam Shomron Twitter Account  Noam Shomron News  Noam Shomron on Facebook
Vice President
Daryl Spinner
  Daryl Spinner LinkedIn Profile  Daryl Spinner Twitter Account  Daryl Spinner News  Daryl Spinner on Facebook
VP - Customer Service
Tomer Jackman
  Tomer Jackman LinkedIn Profile  Tomer Jackman Twitter Account  Tomer Jackman News  Tomer Jackman on Facebook
VP - Marketing
Jennifer Hogan
  Jennifer Hogan LinkedIn Profile  Jennifer Hogan Twitter Account  Jennifer Hogan News  Jennifer Hogan on Facebook
VP - Sales
Chris Zerwas
  Chris Zerwas LinkedIn Profile  Chris Zerwas Twitter Account  Chris Zerwas News  Chris Zerwas on Facebook



Browse more venture capital transactions:

Prev: 3/16/2021: Graphite Bio venture capital transaction
Next: 3/16/2021: UpSwot venture capital transaction


Share this article


Where The Data Comes From

Our team works diligently to record tech company VC transactions. VC investment data records on this site are derived from news reports and company announcements. The data comes to us via our partnership with, an affiliated venture.


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities


Business Glossary